By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Johnson & Johnson Innovation 

99 El Camino Real

Menlo Park  California  94025  U.S.A.
Phone: n/a Fax: n/a


The California Innovation Center is part of Johnson & Johnson Innovation, a division of Johnson & Johnson Finance Corporation. Johnson & Johnson Innovation focuses on accelerating early innovation and enhancing opportunities for collaboration and investment across Johnson & Johnson’s global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies focused on early-stage opportunities a one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and diagnostics and consumer companies of Johnson & Johnson. Johnson & Johnson Innovation includes local deal-making capabilities with the flexibility to adapt deal structures to match early-stage opportunities and establish novel collaborations that speed development of those innovations to solve unmet needs in patients. More information can be found here:

Key Statistics

Ownership: Subsidiary

Web Site: Johnson & Johnson Innovation
Symbol: JNJ


Company News
Phagelux Announces Collaboration With Johnson & Johnson Innovation (JNJ) For New Antibacterial Solution 4/12/2017 10:02:07 AM
Johnson & Johnson Innovation (JNJ) Launches Advancing The Safe Use Of Healthcare Products QuickFire Challenge 3/30/2017 10:38:00 AM
Akebia (AKBA) Licenses Portfolio Of Novel HIF Compounds From Johnson & Johnson Innovation (JNJ) 2/13/2017 6:23:54 AM
Q Biomed Announces Mannin Research Accepted Into Johnson & Johnson Innovation (JNJ), JLABS @ Toronto 2/6/2017 8:57:42 AM
Orthocell Release: Company Announces Collaboration With Johnson & Johnson Innovation (JNJ) 1/12/2017 9:52:01 AM
Johnson & Johnson Innovation (JNJ) Release: Biotech, New York State And New York Genome Center Collaborate To Launch JLABS In New York City 1/9/2017 11:13:04 AM
Synthetic Genomics, Inc. Announces Collaboration With Johnson & Johnson Innovation (JNJ) To Develop Novel Therapeutics Using Synthetic Genomics' Replicon RNA Technology 1/5/2017 7:34:01 AM
Amorsa Therapeutics Announces Strategic Collaboration Facilitated By Johnson & Johnson Innovation (JNJ) To Develop New Therapy For Treatment-Resistant Depression 1/5/2017 6:54:18 AM
Johnson & Johnson Innovation (JNJ) And Janssen Award U.S. $1.5 Million In Grants For World Without Disease Quickfire Challenge 11/15/2016 6:59:39 AM
BioMed X Announces The Start Of New Research Team On Oral Biofilm Disruption Through Continued Collaboration With Johnson & Johnson Innovation (JNJ) 9/6/2016 11:25:12 AM